JOHNSON INVESTMENT COUNSEL INC
Position in NBIX — Neurocrine Biosciences Inc
CIK 821197
Cincinnati, OH
Position in NBIX
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,396,133
New position
Shares Held
14,217
first reported quarter
Ownership
0.014%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#291
of 768 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 12%
Shared 0%
None 88%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JOHNSON INVESTMENT COUNSEL INC holds $19,864,038 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (12.1% of the industry book) .
All Filings in NBIX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,396,133 | 14,217 | Shares | Sole | 2026-07-23 | |
| No filing history on record for this holder in this stock. | ||||||